Omega Healthcare Announces Senior Leadership Changes to Usher in the Next Phase of its Growth Journey

Omega Healthcare Management Services (“Omega”), a leading provider of technology-enabled business process services across the healthcare ecosystem, announced today that co-founder and current Chief Executive Officer Gopi Natarajan has decided to retire after 18 years of leading the firm. Co-founder and President Anurag Mehta have been appointed as the Company’s new Chief Executive Officer, effective November 01, 2021.

Gopi co-founded Omega Healthcare in 2003 with Anurag Mehta and has been instrumental in building the company to be the leader in the tech-enabled healthcare solutions industry. He has had a tremendous impact on Omega, mentored the firm’s senior leadership over the years, and helped drive innovations in the healthcare industry. “As a platform, Omega is extremely well positioned in the healthcare services market to continue to be a leader. With Anurag and Sumithra at the helm, the company is poised to scale greater heights supported by the able senior leadership talent. I wish them the very best in their new roles,” Gopi commented. He will continue to be closely associated with Omega as a key advisor to the Company in several capacities.

“I have had the privilege of working with Gopi for over 20 years now. Not only has he been an invaluable leader for Omega, but he has also been an incredible business partner and friend. I am delighted that he will stay connected as an advisor to the company. I would also like to congratulate Sumithra on her new role. Her invaluable experience will help Omega strengthen its market-leading position,” said Anurag. With more than 20 years of experience within the healthcare industry, Anurag will be instrumental in driving the Company’s next phase of expansion. As a co-founder of Omega, Anurag has a deep understanding of the business and is well poised to spearhead the organization into its next phase of growth with his strong leadership and extensive healthcare industry relationships.

Omega also announced today that a current member of the Board of Directors, Sumithra Gomatam, has been appointed as the Executive Chair of the Omega board. Sumithra brings over 30 years of experience in the information technology and business process services industry. She most recently held several senior roles at Cognizant, a publicly-listed global professional services company, where she spent over 24 years. At Cognizant, she was President of Digital Operations, which she scaled to nearly $2 Billion in revenues and transformed it to be technology-driven with Intelligent Process Automation and Platforms and a significant focus on Healthcare and Big Tech clients. Prior to that, she was at Tata Consultancy Services, a publicly-listed global IT services, consulting, and business solutions organization. “It has been a pleasure to work with the Omega team for the last year. I look forward to continue to work closely with the Omega leadership to accelerate growth in the business, provide customer excellence, and drive deeper technology into our processes,” Sumithra noted. She will strengthen the leadership and work closely with Anurag and the senior management team to drive strategy and scale the organization.

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.